Faiao-Flores et al. [21] also showed that BNCT treatment reduced the cells in G0/G1 and G2/M phases, which was proven by the reduction of cyclin D1, and increased amounts of fragmented DNA in melanoma cells. The gene discussed is CCND1; the disease is melanoma.